✦ LIBER ✦

A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial

✍ Scribed by Lloyd, A.; Holman, A.; Evers, T.

Book ID: 120429693
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 321 KB
Volume: 24
Category: Article
ISSN: 0300-7995
DOI: 10.1185/030079908X280400

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PRS2 A COST-MINIMIZATION ANALYSIS COMPAR

PRS2 A COST-MINIMIZATION ANALYSIS COMPARING MOXIFLOXACIN VERSUS LEVOFLOXACIN AND CEFTRIAXONE FOR THE TREATMENT OF PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA: RESULTS FROM THE MOTIVTRIAL

✍ AC Lloyd; AJ Hoi man 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PIN29 AZITHROMYCIN PLUS CEFTRIAXONE VERS

PIN29 AZITHROMYCIN PLUS CEFTRIAXONE VERSUS LEVOFLOXACIN IN THE TREATMENT OF HOSPITALIZED PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA IN SPAIN. A COST-MINIMIZATION ANALYSIS

✍ J Barbera; B Martí; M Garcia; E Escudero López-Cepero 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

A randomised, double-blind trial compari

A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation

✍ Susan C. Nicholson; Tobias Welte; Thomas M. File Jr; Richard S. Strauss; Bart Mi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 262 KB

PRS5 COST—EFFECTIVENESS ANALYSIS OF FIRS

PRS5 COST—EFFECTIVENESS ANALYSIS OF FIRST LINE ANTIBIOTICS FOR THE INPATIENT TREATMENT OF PATIENTS WITH COMMUNITY ACQUIRE PNEUMONIA IN A PUBLIC MEXICAN HOSPITAL

✍ G Salinas-Escudero; I Contreras-Hernandez; J Mould-Quevedo; G Davila-Loaiza 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Randomized, Double-Blind, Multicenter Ph

Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia

✍ Oldach, D.; Clark, K.; Schranz, J.; Das, A.; Craft, J. C.; Scott, D.; Jamieson, 📂 Article 📅 2013 🏛 American Society for Microbiology 🌐 English ⚖ 253 KB

Cost-Effectiveness of Mirabegron Compare

Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom: Results from a Trial-Based Model

✍ Aballéa, S.; Maman, K.; Desroziers, K.; Nazir, J.; Odeyemi, I.A.O.; Hakimi, Z.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB